Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p

REFERENCE

• Harding T, Baughn L, Kumar S, Van Ness B. 2019. The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies. Leukemia 33:863–883. https://doi.org/10.1038/s41375-018-0362-z.
   PubMed Web of Science ®Google Scholar
• Vélez R, Turesson I, Landgren O, Kristinsson SY, Cuzick J. 2016. Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends. BMJ Open 6:e009584. https://doi.org/10.1136/bmjopen-2015-009584.
   PubMed Web of Science ®Google Scholar
• Leng S, Chen Y, Tsai W-Y, Bhutani D, Hillyer GC, Lim E, Accordino MK, Wright JD, Hershman DL, Lentzsch S, Neugut AI. 2019. Use of bisphosphonates in elderly patients with newly diagnosed multiple myeloma. J Natl Compr Canc Netw 17:22–28. https://doi.org/10.6004/jnccn.2018.7079.
   PubMed Web of Science ®Google Scholar
• Brioli A, Klaus M, Sayer H, Scholl S, Ernst T, Hilgendorf I, Scherag A, Yomade O, Schilling K, Hochhaus A, Mügge L-O, von Lilienfeld-Toal M. 2019. The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey. Ann Hematol 98:713–722. https://doi.org/10.1007/s00277-019-03621-1.
   PubMed Web of Science ®Google Scholar
• Chen D, Zhou D, Xu J, Zhou R, Ouyang J, Chen B. 2019. Prognostic value of 1q21 gain in multiple myeloma. Clin Lymphoma Myeloma Leuk 19:e159–e164. https://doi.org/10.1016/j.clml.2018.12.002.
   PubMed Web of Science ®Google Scholar
• Senín A, García-Pallarols F, Azaiz RB, Martínez-Serra L, Montesdeoca S, Román D, Ferraro M, Párraga I, Besses C, Abella E. 2019. Study of the frequency and reasons for discontinuation of different lines of treatment in patients with multiple myeloma. Ann Hematol 98:705–711. https://doi.org/10.1007/s00277-019-03601-5.
   PubMed Web of Science ®Google Scholar
• Lambert J-P, Picaud S, Fujisawa T, Hou H, Savitsky P, Uusküla-Reimand L, Gupta GD, Abdouni H, Lin Z-Y, Tucholska M, Knight JDR, Gonzalez-Badillo B, St-Denis N, Newman JA, Stucki M, Pelletier L, Bandeira N, Wilson MD, Filippakopoulos P, Gingras A-C. 2019. Interactome rewiring following pharmacological targeting of BET bromodomains. Mol Cell 73:621–638. https://doi.org/10.1016/j.molcel.2018.11.006.
   PubMed Web of Science ®Google Scholar
• Ren C, Zeng L, Zhou MM. 2016. Chapter fourteen–preparation, biochemical analysis, and structure determination of the bromodomain, an acetyl-lysine binding domain. Methods Enzymol 573:321–343. https://doi.org/10.1016/bs.mie.2016.01.018.
   PubMed Web of Science ®Google Scholar
• Ren W, Wang C, Wang Q, Zhao D, Zhao K, Sun D, Liu X, Han C, Hou J, Li X, Zhang Q, Cao X, Li N. 2017. Bromodomain protein Brd3 promotes Ifnb1 transcription via enhancing IRF3/p300 complex formation and recruitment to Ifnb1 promoter in macrophages. Sci Rep 7:39986. https://doi.org/10.1038/srep39986.
   PubMed Web of Science ®Google Scholar
• Hensel T, Giorgi C, Schmidt O, Calzada-Wack J, Neff F, Buch T, Niggli FK, Schäfer BW, Burdach S, Richter G. 2016. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma. Oncotarget 7:1451–1463. https://doi.org/10.18632/oncotarget.6385.
   PubMedGoogle Scholar
• Stubbs MC, Burn TC, Sparks R, Maduskuie T, Diamond S, Rupar M, Wen X, Volgina A, Zolotarjova N, Waeltz P, Favata M, Jalluri R, Liu H, Liu XM, Li J, Collins R, Falahatpisheh N, Polam P, DiMatteo D, Feldman P, Dostalik V, Thekkat P, Gardiner C, He X, Li Y, Covington M, Wynn R, Ruggeri B, Yeleswaram S, Xue C-B, Yao W, Combs AP, Huber R, Hollis G, Scherle P, Liu PCC. 2019. The novel bromodomain and extraterminal domain inhibitor INCB054329 induces vulnerabilities in myeloma cells that inform rational combination strategies. Clin Cancer Res 25:300–311. https://doi.org/10.1158/1078-0432.CCR-18-0098.
   PubMed Web of Science ®Google Scholar
• Schmidt J, Braggio E, Kortuem KM, Egan JB, Zhu YX, Xin CS, Tiedemann RE, Palmer SE, Garbitt VM, McCauley D, Kauffman M, Shacham S, Chesi M, Bergsagel PL, Stewart AK. 2013. Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276. Leukemia 27:2357–2365. https://doi.org/10.1038/leu.2013.172.
   PubMed Web of Science ®Google Scholar
• Xu YJ, Zhou R, Zong JF, Lin WS, Tong S, Guo QJ, Lin C, Lin SJ, Chen YX, Chen MR. 2019. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway. Cancer Lett 447:33–40. https://doi.org/10.1016/j.canlet.2019.01.022.
   PubMed Web of Science ®Google Scholar
• Bogedale K, Jagannathan V, Gerber V, Unger L. 2019. Differentially expressed miRNAs, including a large microRNA cluster on chromosome 24, are associated with equine sarcoid and squamous cell carcinoma. Vet Comp Oncol 17:155. https://doi.org/10.1111/vco.12458.
   PubMed Web of Science ®Google Scholar
• Jiang J, Chang W, Fu Y, Gao Y, Zhang S. 2019. SAV1, regulated by microRNA-21, suppresses tumor growth in colorectal cancer. Biochem Cell Biol 97:91–99. https://doi.org/10.1139/bcb-2018-0034.
   PubMedGoogle Scholar
• Ramchandani D, Lee SK, Yomtoubian S, Han MS, Tung CH, Mittal V. 2019. Nanoparticle delivery of miR-708 mimetic impairs breast cancer metastasis. Mol Cancer Ther 18:579–591. https://doi.org/10.1158/1535-7163.MCT-18-0702.
   PubMed Web of Science ®Google Scholar
• Wang X, Ha T, Liu L, Hu Y, Kao R, Kalbfleisch J, Williams D, Li C. 2018. TLR3 mediates repair and regeneration of damaged neonatal heart through glycolysis dependent YAP1 regulated miR-152 expression. Cell Death Differ 25:966–982. https://doi.org/10.1038/s41418-017-0036-9.
   PubMed Web of Science ®Google Scholar
• Lu Z-W, Du M-Y, Qian L-X, Zhang N, Gu J-J, Ding K, Wu J, Zhu H-M, He X, Yin L. 2018. MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma. Onco Targets Ther 11:1733. https://doi.org/10.2147/OTT.S154464.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang YE, Zhang Y, Leleu X, Reagan M, Zhang Y, Mishima Y, Glavey S, Manier S, Sacco A, Jiang B, Roccaro AM, Ghobrial IM. 2014. Global epigenetic regulation of microRNAs in multiple myeloma. PLoS One 9:e110973. https://doi.org/10.1371/journal.pone.0110973.
   Google Scholar
• Wang M, Zhou L, Yu F, Zhang Y, Li P, Wang K. 2019. The functional roles of exosomal long non-coding RNAs in cancer. Cell Mol Life Sci 76:2059–2076. https://doi.org/10.1007/s00018-019-03018-3.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Gao L, Ma S, Ma J, Wang Y, Li S, Ding Z. 2019. MALAT1-KTN1-EGFR regulatory axis promotes the development of cutaneous squamous cell carcinoma. Cell Death Differ 26:2061–2073. https://doi.org/10.1038/s41418-019-0288-7.
   PubMed Web of Science ®Google Scholar
• Zhou J, Xu J, Zhang L, Liu S, Ma Y, Wen X, Hao J, Li Z, Ni Y, Li X, Zhou F, Li Q, Wang F, Wang X, Si Y, Zhang P, Liu C, Bartolomei M, Tang F, Liu B, Yu J, Lan Y. 2019. Combined single-cell profiling of lncRNAs and functional screening reveals that H19 is pivotal for embryonic hematopoietic stem cell development. Cell Stem Cell 24:285–298. https://doi.org/10.1016/j.stem.2018.11.023.
   PubMed Web of Science ®Google Scholar
• Pan Y, Chen H, Shen X, Wang X, Ju S, Lu M, Cong H. 2018. Serum level of long noncoding RNA H19 as a diagnostic biomarker of multiple myeloma. Clin Chim Acta 480:199–205. https://doi.org/10.1016/j.cca.2018.02.019.
   PubMed Web of Science ®Google Scholar
• Mercurio A, Adriani G, Catalano A, Carocci A, Rao L, Lentini G, Cavalluzzi MM, Franchini C, Vacca A, Corbo F. 2017. A mini-review on thalidomide: chemistry, mechanisms of action, therapeutic potential and anti-angiogenic properties in multiple myeloma. Curr Med Chem 24:2736. https://doi.org/10.2174/0929867324666170601074646.
   PubMed Web of Science ®Google Scholar
• De BN, Menu E, Bertrand MJ, Favreau M, De BE, Maes K, De VK, Radwanska M, Samali A, Magez S. 2017. Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells. Oncotarget 8:52016–52025. https://doi.org/10.18632/oncotarget.18152.
   PubMedGoogle Scholar
• Dalia BL, Lau SK, Boutros PC, Fereshteh K, Igor J, Andrulis IL, Tsao MS, Penn LZ. 2006. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 66:5330. https://doi.org/10.1158/0008-5472.CAN-06-0037.
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhang Y, Liu W, Huang Y, Shen X, Jing R, Pu J, Wang X, Ju S, Cong H. 2019. LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p. Cell Death Dis 10:106. https://doi.org/10.1038/s41419-018-1219-0.
   PubMed Web of Science ®Google Scholar
• Sun Y, Pan J, Zhang N, Wei W, Yu S, Ai L. 2017. Knockdown of long non-coding RNA H19 inhibits multiple myeloma cell growth via NF-κB pathway. Sci Rep 7:18079. https://doi.org/10.1038/s41598-017-18056-9.
   PubMed Web of Science ®Google Scholar
• Liu C, Chen Z, Fang J, Xu A, Zhang W, Wang Z. 2016. AB144. H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation. Tumour Biol 37:263–270. https://doi.org/10.21037/tau.2016.s144.
   PubMedGoogle Scholar
• Liu G, Xiang T, Wu QF, Wang WX. 2016. Long noncoding RNA H19-derived miR-675 enhances proliferation and invasion via RUNX1 in gastric cancer cells. Oncol Res 23:99–107. https://doi.org/10.3727/096504015X14496932933575.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu CY, Wan Y, Peng L, Li WF, Qiu JX. 2016. Long non-coding RNA H19 promotes the proliferation of fibroblasts in keloid scarring. Oncol Lett 12:2835. https://doi.org/10.3892/ol.2016.4931.
   PubMed Web of Science ®Google Scholar
• Xu Y, Chen B, George SK, Liu B. 2015. Downregulation of microRNA-152 contributes to high expression of DKK1 in multiple myeloma. RNA Biol 12:1314–1322. https://doi.org/10.1080/15476286.2015.1094600.
   PubMed Web of Science ®Google Scholar
• Sun J, Tian X, Zhang J, Huang Y, Lin X, Chen L, Zhang S. 2017. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2. J Exp Clin Cancer Res 36:100. https://doi.org/10.1186/s13046-017-0567-4.
   PubMed Web of Science ®Google Scholar
• He ZY, Wei TH, Zhang PH, Zhou J, Huang XY. 2019. Long noncoding RNA-antisense noncoding RNA in the INK4 locus accelerates wound healing in diabetes by promoting lymphangiogenesis via regulating miR-181a/Prox1 axis. J Cell Physiol 234:4627–4640. https://doi.org/10.1002/jcp.27260.
   PubMed Web of Science ®Google Scholar
• Chen DL, Lu YX, Zhang JX, Wei XL, Wang F, Zeng ZL, Pan ZZ, Yuan YF, Wang FH, Pelicano H, Chiao PJ, Huang P, Xie D, Li YH, Ju HQ, Xu RH. 2017. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression. Theranostics 7:4836–4849. https://doi.org/10.7150/thno.20942.
   PubMed Web of Science ®Google Scholar
• Ding J, Yeh CR, Sun Y, Lin C, Chou J, Ou Z, Chang C, Qi J, Yeh S. 2018. Estrogen receptor beta promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network. Oncogene 37:5037–5053. https://doi.org/10.1038/s41388-018-0175-6.
   PubMed Web of Science ®Google Scholar
• Cazalla D, Yario T, Steitz JA, Steitz J. 2010. Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 328:1563–1566. https://doi.org/10.1126/science.1187197.
   PubMed Web of Science ®Google Scholar
• White ME, Fenger JM, Carson WE. 2019. Emerging roles of and therapeutic strategies targeting BRD4 in cancer. Cell Immunol 337:48. https://doi.org/10.1016/j.cellimm.2019.02.001.
   PubMed Web of Science ®Google Scholar
• Guo NH, Zheng JF, Zi FM, Cheng J. 2019. I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targeting BRD4 in multiple myeloma. Biosci Rep 39:BSR20181245. https://doi.org/10.1042/BSR20181245.
   PubMed Web of Science ®Google Scholar
• Xiang T, Bai JY, She C, Yu DJ, Zhou XZ, Zhao TL. 2018. Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma. Cell Signal 42:106–113. https://doi.org/10.1016/j.cellsig.2017.10.010.
   PubMed Web of Science ®Google Scholar